SURF - SUrvey of Risk Factor management: First report of an international audit

European Journal of Preventive Cardiology

Volumn 21, Issue 7, 2014, Pages 813-822

  Cooney, M T ^a   Reiner, Z ^b   Sheu, W ^c   Ryden, L ^d   Sutter, J De ^e   De Bacquer, D ^f   Debacker, G ^f   Mithal, A ^g   Chung, N ^h   Lim, Y T ⁱ   Dudina, A ^a   Reynolds, A ^a   Dunney, K ^a   Graham, I ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

^b KBC Zagreb   (Croatia)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d KAROLINSKA INSTITUTE   (Sweden)

^e Maria Middelares Hospital   (Belgium)

^f GHENT UNIVERSITY   (Belgium)

^g Medicity   (India)

^h Yonsei University College of Medicine   (South Korea)

ⁱ MOUNT ELIZABETH MEDICAL CENTRE   (Singapore)

Author keywords

Cardiovascular disease; global trends; risk factors; secondary prevention

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRIC ACID DERIVATIVE; ANGIOTENSIN RECEPTOR ANTAGONIST; CARDIOVASCULAR AGENT; CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL;

ADULT; ARTICLE; ASIA; BLOOD PRESSURE REGULATION; CORONARY ARTERY BYPASS GRAFT; EUROPE; FEMALE; HEART REHABILITATION; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE; MALE; MEDICAL AUDIT; OBESITY; PERCUTANEOUS CORONARY INTERVENTION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK FACTOR; RISK MANAGEMENT; SMOKING; ABDOMINAL OBESITY; ACUTE CORONARY SYNDROME; AGED; BELGIUM; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CROATIA; DEMOGRAPHY; DIABETES MELLITUS; DYSLIPIDEMIA; GLYCEMIC CONTROL; HEART RATE; HIGH RISK POPULATION; HYPERTENSION; INDIA; IRELAND; KOREA; MAJOR CLINICAL STUDY; MEDICAL HISTORY; PHYSICAL INACTIVITY; PILOT STUDY; PRACTICE GUIDELINE; SECONDARY PREVENTION; SEX DIFFERENCE; SINGAPORE; SURVEY OF RISK FACTOR MANAGEMENT; TAIWAN; WAIST CIRCUMFERENCE; CLINICAL TRIAL; COMPLICATION; CORONARY DISEASE; DISEASE MANAGEMENT; INFORMATION PROCESSING; MIDDLE AGED; MULTICENTER STUDY;

ADULT; AGED; ASIA; BLOOD PRESSURE; CORONARY DISEASE; DATA COLLECTION; DIABETES COMPLICATIONS; DISEASE MANAGEMENT; EUROPE; FEMALE; HUMANS; HYPERTENSION; MALE; MEDICAL AUDIT; MIDDLE AGED; PILOT PROJECTS; RISK FACTORS; SECONDARY PREVENTION; SEX FACTORS;

EID: 84902585277     PISSN: 20474873     EISSN: 20474881     Source Type: Journal    
DOI: 10.1177/2047487312467870     Document Type: Article

References (15)

1. World Health Organiaation. Available at: www.who.int (consulted March 2009).
2. Baigent C, Keech A, Kearney P, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet. 2008 ; 366: 1267-1278
3. Staessen J, Wang J, Thijs L. Cardiovascular protection and blood pressure reduction: a meta-analysis. Lancet. 2001 ; 358: 1305-1315
4. Reiner Z. How to improve cardiovascular diseases prevention in Europe?. Nutr Metab Cardiovasc Dis. 2009 ; 19: 451-454
5. Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007 ; 14 Suppl 2: S1 - S113
6. Kotseva K, Wood D, De Backer G, et al. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. Eur J Cardiovasc Prev Rehabil. 2009 ; 16: 121-137
7. Kotseva K, Wood D, De Backer G, et al. Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries. Lancet. 2009 ; 373: 929-940
8. Catapano AL, Reiner Z, De Backer G, et al. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis. 2011 ; 217 Suppl 1: S1 - S44
9. Vikram NK, Pandey RM, Misra A, et al. Non-obese (body mass index?
10. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004 ; 363: 157-163
11. Zheng W, McLerran DF, Rolland B, et al. Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med. 2011 ; 364: 719-729
12. Wildman RP, Gu D, Reynolds K, et al. Appropriate body mass index and waist circumference cutoffs for categorization of overweight and central adiposity among Chinese adults. Am J Clin Nutr. 2004 ; 80: 1129-1136
13. De Bacquer D, Dallongeville J, Heidrich J, et al. Management of overweight and obese patients with coronary heart disease across Europe. Eur J Cardiovasc Prev Rehabil. 2010 ; 17: 447-454
14. Reiner Z, Sonicki Z, Tedeschi-Reiner E. Public perceptions of cardiovascular risk factors in Croatia: the PERCRO survey. Prev Med. 2010 ; 51: 494-496
15. Reiner Z, Sonicki Z, Tedeschi-Reiner E. Physicians' perception, knowledge and awareness of cardiovascular risk factors and adherence to prevention guidelines: the PERCRO-DOC survey. Atherosclerosis. 2010 ; 213: 598-603